Latest News
Mar 31, 2025
people bidding at auction with two people holding a 3 and a 9 paddle
Partnering
Rival takeover: bluebird bio bags new bid from Ayrmid
Rival takeover: bluebird bio bags new bid from Ayrmid
Ayrmid – parent company of Gamida Cell – has proposed to buy bluebird for 50% more than the offer agreed with Carlyle and SK Capital Partners.
Connecting China’s Biotech Innovations with the Global Life Science Ecosystem through cross-border partnerships.
REGISTERNews from APAC
See all
Life Sciences Investment, Streamline Your Path to Capital with Strategic Partnerships and Insights
REGISTERBIO-EUROPE COVERAGE
BIO-EUROPE COVERAGE
C-Suite Conversations
See all
partneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
Rival takeover: bluebird bio bags new bid from Ayrmid
Ayrmid – parent company of Gamida Cell – has proposed to buy bluebird for 50% more than the offer agreed with Carlyle and SK Capital Partners.
Eyes on Asia: Novo Nordisk, AZ, Merck, and Taiho
BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 30 March.
Winning strategies: Bayer bares all on ‘arm’s length’ acquisitions
Bayer shared their insights with us on the benefits, challenges, and operational framework of an "arm's length" acquisition.
Outsourcing
See all
Sponsored Content
Mar 14, 2025
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.